AstraZeneca has received approval from the Emirates Drug Establishment (EDE) in the UAE for Baxfendy, a medicine using the active ingredient baxdrostat, for uncontrolled hypertension.
The acquisition would improve Seattle Genetics' late-stage clinical pipeline with Tucatinib, an orally available and highly selective tyrosine kinase inhibitor (TKI) for patients with HER2-positive metastatic breast cancer As per the terms
TAK-426 is a purified, inactivated, alum-adjuvanted and whole Zika virus vaccine candidate. Zika holds capacity to induce congenital Zika syndrome (CZS), including microcephaly and other congenital brain abnormalities,
The Phase I/II study (STELLAR-001) will evaluate the safety and efficacy of durvalumab, an anti-PD-L1 immune checkpoint inhibitor, in combination with Innate's investigational first-in-class anti-C5aR monoclonal antibody, IPH5401,
The company has announced the top-line results from the Phase III KRONOS trial, which showed PT010 (budesonide/glycopyrronium/formoterol fumarate 320/14.4/9.6µg, using Aerosphere Delivery Technology, in a pressurised metered-dose inhaler
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.
